EUVIMEDEUVIMED entdecken
Crossref

Pharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia

S.K. Zyryanov, I.N. Dyakov

Medical Technologies. Assessment and Choice · 2020

DOI: 10.17116/medtech20204002150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Technologies. Assessment and Choice, 2020. Verfasst von S.K. Zyryanov und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zyryanov, S., & Dyakov, I. (2020). Pharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia. Medical Technologies. Assessment and Choice. https://doi.org/10.17116/medtech20204002150

Vancouver

Zyryanov S, Dyakov I. Pharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia. Medical Technologies. Assessment and Choice. 2020. doi:10.17116/medtech20204002150

BibTeX
@article{Zyryanov2020,
  author = {Zyryanov, S.K. and Dyakov, I.N.},
  title = {Pharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia},
  journal = {Medical Technologies. Assessment and Choice},
  year = {2020},
  doi = {10.17116/medtech20204002150}
}
Kostenlos starten →